Assam Reporter

CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers

 Breaking News
  • No posts were found

CD Bioparticles Expands Its Biodegradable Polymers Portfolio with Dendrimers

March 02
00:49 2021
CD Bioparticles recently introduces a series of dendrimers for researchers.

New York, USA – March 1, 2021 – As a leading manufacturer and supplier of various drug delivery products and services, CD Bioparticles recently introduces a series of dendrimers for research use, such as DMPA-G1-TMP-Acetylene, DMPA-G1-TMP-Azide, DMPA-G1-TMP-Carboxyl, and DMPA-G1-TMP-NHBOC. These biodegradable polymers can be used in theranostics, biosensors, optics, adhesives and coatings.

With customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms, CD Bioparticles can help scientists to solve problems in the studies, such as limited options for the bio-conjugation between macromolecules and biomolecules, and unpredictable or uncontrollable degradation rate of the drug-loading cargo. These newly released dendrimers products are organized by functional groups, such as ammonium, acetylene, azide, hydroxyl and cardoxyl.

Many new products now are available at CD Bioparticles, such as the DMPA Acetylene Dendrimer, one of the newly released dendrimers. DMPA Acetlyene dendrimers are monodisperse, multifunctional scaffolds with an exact number of surface groups. These alkyne functional dendrimers can be used for various click chemistry reactions, such as CuAAC and Thiol-Yne coupling. The dendritic polymer is biodegradable and have low cytotoxicity, and can be used in theranostics, biosensors, optics, adhesives and coatings.

“If you want to get rid of tedious chemical synthesis and purifications, uncontrollable drug delivery profile, or biomolecules denatured during the conjugation, or want to have more options for material solidification which gives you the choice of the materials for additive manufacturing precision medicine, CD Bioparticles is your best partner. We can help you more in drug delivery.” said Prof. Jeffrey A. Depaul, M.D., the chief scientific officer of R&D department of CD Bioparticles.

“The dendrimers complement our existing offerings and immediately provide our drug delivery research customers with more options and flexibility for related studies. And we’ll make efforts to offer a broader menu of biodegradable polymers to meet increasing demand of our customers.” said Dr. Robin J. Watts, the product portfolio manager of CD Bioparticles.

For more detailed information on dendrimers or biopolymers & synthetic polymers, please contact CD Bioparticles or visit its website directly at https://www.cd-bioparticles.net.

About CD Bioparticles

CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems. It specializes in a range of formulation and drug delivery technologies, from conventional liposomes, PEGylated liposomes for drug delivery to polymer microspheres and nanoparticles for enhanced drug delivery. It provides contract services of drug delivery formulation developments for basic research, formulation feasibility studies, process development and scale-up, formulation characterization, analytical and nonclinical services.

Media Contact
Company Name: CD Bioparticles
Contact Person: Richard J. Gray
Email: Send Email
Phone: 1-631-346-0027
Country: United States
Website: https://www.cd-bioparticles.net

Related Articles